A new approach to labeling cells with technetium-99m, part II. Evaluation of radiolabeled human-lymphocyte immune functions

Nuclear Medicine and Biology

Volumn 23, Issue 1, 1996, Pages 87-95

  Delmon Moingeon, Laurence I ^a   Mahmood, Ashfaq ^a   Davison, Alan ^b   Jones, Alun G ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c Shields Warren Radiation Laboratory   (United States)

Author keywords

99mTc lymphocytes; 99mTc N acetyl homocysteinyl polylysine; 99mTc polycation; 99mTc polylysine; N acetyl homocysteinyl polylysine

Indexed keywords

LYMPHOCYTE MEMBRANE RECEPTOR; POLYLYSINE; TECHNETIUM 99M;

ARTICLE; HUMAN; ISOTOPE LABELING; LYMPHOCYTE; LYMPHOCYTE FUNCTION;

ANTIBODIES, MONOCLONAL; AUTORADIOGRAPHY; CELL DIVISION; CELL FUSION; CELL LINE; CELL SURVIVAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; HYDROGEN-ION CONCENTRATION; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; ORGANOTECHNETIUM COMPOUNDS; POLYLYSINE; T-LYMPHOCYTES; TEMPERATURE;

EID: 0030052569     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(95)02011-X     Document Type: Article

References (29)

1. Balaban E. P., Simon T. R. and Frenkel E. P. (1987) Toxicity of indium-111 on the radiolabeled lymphocyte. J. Nucl. Med. 28, 229-233.
2. Boldt D. H., Mills B. J., Gemlo B. T., Holden H., Mier J., Paietta E., McMannis J. D., Escobedo L. V., Sniecinski I., Rayner A. A., Hawkins M. J., Atkins M. B., Ciobanu N. and Ellis T. M. (1988) Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humans. Cancer Res. 48, 4409-4416.
3. m-hexamethyl-propyleneamine oxime. Nucl. Med. Commun. 9, 465-475.
4. Dutcher J. P., Creekmore S., Weiss G. R., Margolin K., Markowitz A. B., Roper M., Parkinson D., Ciobanu N., Fisher R. I., Boldt D. H., Doroshow J. H., Rayner A. A., Hawkins M. and Atkins M. (1989) A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma. J. Clin. Oncol. 7, 477-485.
5. Ehrlich P. (1956) In The Collected Papers of Paul Ehrlich, vol. 2 (Edited by Himmelweit F.), pp. 550-562. Pergamon Press, London.
6. Freeman L. M. and Blaufox M. D., eds. (1984) Cell labeling-Part I. Semin. Nucl. Med. 14, 67-140.
7. Fueger G. F., ed. (1984) Blood Cells in Nuclear Medicine, Part II. Migratory Blood Cells. Martinus Nijhoff Publishers, Boston.
8. Hardeman M. R. and Najean Y., eds. (1984) Blood Cells in Nuclear Medicine, Part I. Cell Kinetics and Biodistribution. Martinus Nijhoff Publishers, Boston.
9. Kassis A. I. and Adelstein S. J. (1985) Chemotoxicity of indium-111 oxine in mammalian cells. J. Nucl. Med. 26, 187-190.
10. Knapp W., Dorken B., Gilks W. R. et al., eds. (1989) Leucocyte Typing IV: White Cell Differentiation Antigens. Oxford University Press, Oxford.
11. Kradin R. L., Kurnick J. T., Lazarus D. S., Preffer F. I., Dubinett S. M., Pinto C. E., Gifford J., Davidson E., Grove B., Callahan R. J. and Strauss H. W. (1989) Tumor-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer. Lancet 1, 577-580.
12. Mahmood A., Delmon-Moingeon L. I., Limpa-Amara N., Davison A. and Jones A. G. (1996) A new approach to labeling cells with technetium-99m, Part I. Preparation of modified polylysine and in-vitro cell labeling. Nucl. Med. Biol. 23, 81-88.
13. Mule J. J., Shu S., Schwarz S. L. and Rosenberg S. A. (1984) Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 225, 1487-1489.
14. North S. M. and Nicholson G. L. (1987) Host responses and tumor metastasis. In Immune Responses to Metastasis, vol. 1. (Edited by Herberman R. B., Wiltrout R. H. and Gorelik E.), pp. 1-22. CRC Press, Boca Raton, FL.
15. Olszewski W. L. (1987) Lymphocyte traffic in neoplastic diseases. In In Vivo Migration of Immune Cells, pp. 149-153. CRC Press, Boca Raton, FL.
16. 99mTc-hexamethylpropyleneamineoxime for labelling leucocytes and imaging inflammation. Lancet 2, 946-949.
17. Roddie M. E., Peters A. M., Danpure H. J., Osman S., Henderson B. L., Lavender J. P., Carroll M. J., Neinnckx R. D. and Kelly J. D. (1988) Inflammation: Imaging with Tc-99m-HMPAO-labeled leukocytes. Radiology 166, 767-772.
18. Rosenberg S. A. (1984) The adoptive immunotherapy of cancer: Accomplishments and prospects. Cancer Treat. Rep. 68, 233-255.
19. Rosenherg S. A., Lotze M. T., Muul L. M., Chang A. E., Avis F. P., Leitman S., Linehan W. M., Robertson C. N., Lee R. E., Rubin J. T., Seipp C. A., Simpson C. G. and White D. E. (1987) A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N. Engl. J. Med. 316, 889-897.
20. Rosenberg S. A., Lotze M. T., Muul L. M., Leitman S., Chang A. E., Ettinghausen S. E., Matory Y. L., Skibber J. M., Shiloni E., Vetto J. T., Seipp C. A., Simpson C. and Reichert C. M. (1985) Special report: Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancet. N. Engl. J. Med. 313, 1485-1492.
21. Rosenberg S. A., Packard B. S., Aebersold P. M., Solomon D., Topalian S. L., Toy S. T., Simon P., Lotze M. T., Yang J. C., Seipp C. A., Simpson C., Carter C., Bock S., Schwartzentruber D., Wei J. P. and White D. E. (1988) Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N. Engl. J. Med. 319, 1676-1680.
22. Rosenberg S. A., Spiess P. and Lafreniere R. (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233, 1318-1321.
23. Rosenberg S. A. and Terry W. D. (1977) Passive immunotherapy of cancer in animals and man. Adv. Cancer Res. 25, 323-388.
24. Ryser H. J., Drummond I. and Shen W. C. (1982) The cellular uptake of horse-radish peroxidase and its poly(lysine) conjugate by cultured fibroblasts is qualitatively similar despite a 900-fold difference in rates. J. Cell. Physiol. 113, 167-178.
25. Ryser H. J. and Shen W. C. (1986) Drug-polylysine conjugates: Their potential for chemotherapy and for the study of endocytosis. In Targeting Drugs and Synthetic Systems (Edited by Gregoriadis G., Senior J. and Poste G.), pp. 103-121. Plenum Press, New York.
26. Segal A. W., Deteix P., Garcia R., Tooth P., Zanelli G. D. and Allison A. C. (1978) Indium-111 labeling of leukocytes: A detrimental effect on neutrophil and lymphocyte function and an improved method of cell labeling. J. Nucl. Med. 19, 1238-1244.
27. Springer T. A. (1990) Adhesion receptors of the immune system. Nature 346, 425-434.
28. Thakur M. L., Segal A. W., Louis L., Welch M. J., Hopkins J. and Peters T. J. (1977) Indium-111-labeled cellular blood components: Mechanism of labeling and intracellular location in human neutrophils. J. Nucl. Med. 18, 1022-1026.
29. Topalian S. L., Solomon D., Avis F. P., Chang A. E., Freerksen D. L., Linehan W. M., Lotze M. T., Robertson C. N., Seipp C. A., Simon P., Simpson C. G. and Rosenberg S. A. (1988) Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: A pilot study. J. Clin. Oncol. 6, 839-853.